Maria Bech

CEO Maria Bech, has an in-depth knowledge of development strategies, clinical programs and study design, gained from more than 25 years’ experience working across the pharmaceutical industry from global project management to line management of a clinical/R&D dept.

She also serves on the Board of Directors of four companies, of which three are listed: EQL Pharma, Iconovo, Paxman and Neuronano.

​Maria holds an MSc Molecular Biology from the University of Lund.